JOURNAL REVIEW

Authors and experts summarize and discuss newly published research in the peer-reviewed literature

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic arthritis symptom onset and diagnosis to the likelihood and severity of depression, social impairment, and disease impact on quality of life.

Read full article here

Reference:

      1. Zundell MP, Perez-Chada L, Tapryal N, et al. Diagnostic Delay of Psoriatic Arthritis of More Than Six months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional Study. J Clin Aesthet Dermatol. 2024;17(10):19–22.

    MORE JOURNAL REVIEWS

    Journal Review: Andrew Blauvelt

    Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients...

    PLAY

    Journal Review: Linda Stein Gold

    Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe...

    PLAY

    Journal Review: Valerie Callender

    Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach...

    PLAY

    Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read

    Dr. Graber discusses her article published in JCAD January 2025, titled “Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl

    ​Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its

    Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in

    Dr. Tina Bhutani reviews real-world data showing improved patient-reported outcomes and satisfaction with tildrakizumab in moderate-to-severe plaque psoriasis. Topics Covered: Tildrakizumab 100mg over 64 weeks

    James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive

    Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients
    Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe
    Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach
    Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides
    Sabrina Fabi, MD, discusses the article, “Customized Treatment Using Microfocused Ultrasound with Visualization for OptimizedPatient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian